Povadora, Alexa Khamille C.
HRN: 13-86-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2023
CEFUROXIME 750MG (VIAL)
06/14/2023
06/20/2023
IV DRIP
400 Mg
Q8
IRTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes